The management of thrombosis in the antiphospholipid-antibody syndrome.

BACKGROUND: The antiphospholipid-antibody syndrome is a thrombophilic disorder in which venous or arterial thrombosis, or both, may occur in patients with ...

MA Khamashta，G Ruiz-Irastorza - 《N Engl J Med》

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

BACKGROUND: The antiphospholipid-antibody syndrome is a thrombophilic disorder in which venous or arterial thrombosis, or both, may occur in patients with ...

Khamashta，Munther，A.，... - 《New England Journal of Medicine》

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome — NEJM

BACKGROUND: The antiphospholipid-antibody syndrome is a thrombophilic disorder in which venous or arterial thrombosis, or both, may occur in patients with ...

MA Khamashta，MJ Cuadrado，F Mujic，... - 《New England Journal of Medicine》

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

The antiphospholipid-antibody syndrome is a thrombophilic disorder in which venous or arterial thrombosis, or both, may occur in patients with antiphospholipid antibodies. The optimal treatment of these patients is unclear. We assessed t...

MA Khamashta，MJ Cuadrado，F Mujic，... - 《New England Journal of Medicine》

A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome.

Background: Many patients with the antiphospholipid antibody syndrome and recurrent thrombosis receive doses of warfarin adjusted to achieve an internation...

Crowther，A Mark，Ginsberg，... - 《New England Journal of Medicine》

Neuromyelitis Optica and Non–Organ-Specific Autoimmunity

BACKGROUND: Neuromyelitis optica (NMO) is often associated with other clinical or serological markers of non-organ-specific autoimmunity. OBJECTIVE: To eva...

SJ Pittock，VA Lennon，J De Seze，... - 《Arch Neurol》

Human lupus autoantibodies against NMDA receptors mediate cognitive impairment

Neuropsychiatric systemic lupus erythematosus, which often entails cognitive disturbances and memory loss, has become a major complication for lupus patien...

C Kowal，LA Degiorgio，YL Ji，... - 《Proceedings of the National Academy of Sciences of the United States of America》

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry.

The present study shows that: (a) previous thrombosis and ACA titer > 40 U are independent predictors of thrombosis; (b) history of miscarriage or vascular...

G Finazzi，V Brancaccio，MD Marco Moia，... - 《American Journal of Medicine》

Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

OBJECTIVE: To apply the new American College of Rheumatology nomenclature for neuropsychiatric systemic lupus erythematosus (NPSLE), determine the prevalen...

G Sanna，ML Bertolaccini，MJ Cuadrado，... - 《Journal of Rheumatology》

association with antiphospholipid antibodies . Neuropsychiatric Manifestations in Systemic Lupus Erythematosus : Prevalence and Association with Antiphosph...

OBJECTIVE: To apply the new American College of Rheumatology nomenclature for neuropsychiatric systemic lupus erythematosus (NPSLE), determine the prevalen...

G Sanna，ML Bertolaccini，MJ Cuadrado，...